510(k) Report

510(k) · Cleared

Recalled · 2008

Tevadaptor Closed Drug Reconstitution and Transfer System

K051669510(k) TraditionalCleared Sep 1, 200571-day reviewClass II21 CFR 880.5440Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Migada Plant · LHI Set, I.V. Fluid Transfer

Cleared on Sep 1, 2005 as substantially equivalent to K980381 (Carmel Pharma Ab., 1998) after a 71-day review. Its family tree reaches back 3 generations to 1988. 2 of the 19 devices in its family, counting itself, have a Class I recall. 13 later devices descend from it. It has been recalled once.

Decided
Sep 1, 2005
Review
71 days
Class
Class II
Product code
LHI
Recalls
1
Predicates
1

Its longest line of descent runs back 3 generations to K883614 (1988). 5 ancestors in all. 13 later devices descend from it, 2 citing it directly. 2 of the 19 devices in this family, counting this one, have a Class I recall.

Other ancestors, by year clearedDescendants, by year cleared 1995: 1 other ancestor1994: 1 other ancestor2007: 1 descendant cleared, 1 with a Class I recall12009: 2 descendants cleared2014: 2 descendants cleared2010: 1 descendant cleared2017: 2 descendants cleared, 1 with a Class I recall12022: 1 descendant cleared2023: 1 descendant cleared2024: 1 descendant cleared2025: 2 descendants clearedK883614 · Cytoguard (R) · Survival Technology, Inc. · 1988K972527 · Phaseal, System for Sealed Handling of Chemotherapeutic Agents · Quality System Consulting · 1997K980381 · Phaseal, Closed System Forhandling of Parenteral Drugs, Additional Administration Devices. C80 Infusion Adapter, A10 Pro · Carmel Pharma Ab. · 19981990200020102020
Other ancestors, by generationDescendants, by generation 3 generations back: 2 other ancestors 1 generation forward: 2 descendants, 1 with a Class I recall12 generations forward: 3 descendants3 generations forward: 2 descendants, 1 with a Class I recall14 generations forward: 1 descendant5 generations forward: 2 descendants6 generations forward: 1 descendant7 generations forward: 2 descendants K980381 · Phaseal, Closed System Forhandling of Parenteral Drugs, Additional Administration Devices. C80 Infusion Adapter, A10 Pro · Carmel Pharma Ab. · 1998K972527 · Phaseal, System for Sealed Handling of Chemotherapeutic Agents · Quality System Consulting · 1997K883614 · Cytoguard (R) · Survival Technology, Inc. · 19880+5
  1. Root · 3 generations backK883614 Cytoguard (R)Survival Technology, Inc. · 1988
  2. 2 generations backK972527 Phaseal, System for Sealed Handling of Chemotherapeutic AgentsQuality System Consulting · 1997
  3. 1 generation backK980381 Phaseal, Closed System Forhandling of Parenteral Drugs, Additional…Carmel Pharma Ab. · 1998
  4. This deviceK051669 Tevadaptor Closed Drug Reconstitution and Transfer SystemMigada Plant · 2005
  5. Descendant · cites it directly · 9 of its ownK083152 Equashield SystemPlastmed, Ltd. · 2009
  6. Descendant · 2 generations on · 8 of its ownK091389 Equalshield Luer Lock Connector PairPlastmed, Ltd. · 2009
  7. Descendant · 2 generations on · 7 of its ownK101940 Equashield System Protective PlusEquashield Medical, Ltd. · 2010
  8. Descendant · 3 generations on · 6 of its ownK132899 Equashield Closed System Drug Transfer Device (CSTD)Equashield Medical, Ltd. · 2014
  9. Descendant · 4 generations on · 5 of its ownK170706 Equashield Closed System drug Transfer Device (CSTD)Equashield Medical, Ltd. · 2017

Showing 5 of 13 descendants. See all descendants

Descendants cleared per year

2007: 12009: 22010: 12014: 22017: 22022: 12023: 12024: 12025: 2
2007high 2 (2009) · low 0 (2008)2026

Class I recalls in this family

Most influential descendants

Showing 5 of 13 · See all
  • K083152Equashield SystemPlastmed, Ltd. · 2009 · cites it directly9descendants
  • K091389Equalshield Luer Lock Connector PairPlastmed, Ltd. · 2009 · 2 generations on8descendants
  • K101940Equashield System Protective PlusEquashield Medical, Ltd. · 2010 · 2 generations on7descendants
  • K132899Equashield Closed System Drug Transfer Device (CSTD)Equashield Medical, Ltd. · 2014 · 3 generations on6descendants
  • K170706Equashield Closed System drug Transfer Device (CSTD)Equashield Medical, Ltd. · 2017 · 4 generations on5descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K883614Cytoguard (R)Survival Technology, Inc.1988—
−2K972527Phaseal, System for Sealed Handling of Chemotherapeutic AgentsQuality System Consulting1997—
−1K980381Phaseal, Closed System Forhandling of Parenteral Drugs, Additional…Carmel Pharma Ab.1998—
0 (this device)K051669Tevadaptor Closed Drug Reconstitution and Transfer SystemMigada Plant2005—
+1K083152Equashield SystemPlastmed, Ltd.2009—
+2K091389Equalshield Luer Lock Connector PairPlastmed, Ltd.2009—
+2K101940Equashield System Protective PlusEquashield Medical, Ltd.2010—
+3K132899Equashield Closed System Drug Transfer Device (CSTD)Equashield Medical, Ltd.2014—
+4K170706Equashield Closed System drug Transfer Device (CSTD)Equashield Medical, Ltd.2017—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199410
199510

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200711
200920
201010
201420
201721
202210
202310
202410
202520
FIG. 1 — Lineage of K051669, 1988–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

2 devices in this family have a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LHI device

  1. #1 K252987 ADRx™ Admixture Devicescore 12.4 · 4 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K980381Phaseal, Closed System Forhandling of Parenteral Drugs, Additional Administration…
Summary page 4
…ed system for the preparation and administration of parenteral drugs. Carmel Pharma AB. S-402 28 Gottingen, Sweden, cleared under 5 10(k) no. K980381. Description of the device: The device comprises of the following components: - Vial…
Carmel Pharma Ab.1998—

Also cleared against K980381: 6 other devices →

What descends from it? (13)

See all 13

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K083152Equashield SystemPlastmed, Ltd.20099
K072759VIAL2BAG Class IMedimop Medical Projects, Ltd.20072

Has anything in its family been recalled? (2 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Dec 18, 2008Not classifiedZ-1244-2009Component design/selectionSyringe adaptor is disintegrating when attached to the end of the syringe.

Relatives with a Class I recall

Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.

  • K072759VIAL2BAGMedimop Medical Projects, Ltd. · 2007 · Cites it directly · ◆ in the 2007 descendants bar of FIG. 11 Class I recall
  • K170095Vial2Bag Direct ConnectMedimop Medical Project, Ltd. · 2017 · 3 generations on · ◆ in the 2017 descendants bar of FIG. 12 Class I recalls

What does this lineage say?

  • The line of descent spans 17 years and passes through 4 companies; a new generation was cleared every 7.5 years on median.
  • 1 of the 5 ancestors has a recall of any class.
  • Of its descendants, K083152 (Plastmed, Ltd., 2009) has gone furthest, with 9 descendants of its own.
  • 6 other devices also cite its predicate K980381.

How does its category compare?

All LHI devices

LHI Set, I.V. Fluid Transfer: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · LHI

6in 2025

2007: 32008: 42009: 82010: 52011: 32012: 52013: 42014: 62015: 32016: 32017: 52018: 12019: 42020: 32021: 32022: 62023: 52024: 92025: 62026 (partial year): 2
2007high 9 (2024) · low 1 (2018)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LHI

196in 2025

2007: 89 days median2008: 154 days median2009: 95 days median2010: 139 days median2011: 99 days median2012: 127 days median2013: 102 days median2014: 63 days median2015: 99 days median2016: 159 days median2017: 56 days median2019: 247 days median2020: 189 days median2021: 396 days median2022: 278 days median2023: 90 days median2024: 166 days median2025: 196 days median
2007high 396 (2021) · low 56 (2017)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LHI

1in 2024

2007: 12008: 32009: 12010: 32011: 122013: 32016: 1, 1 Class I2017: 12018: 3, 3 Class I2019: 12022: 22023: 2, 2 Class I2024: 12026 (partial year): 1
2007high 12 (2011) · low 0 (2012)2026

Class I (6 since 2007) Class II/III not classified

Adverse event reports per year · LHI

1,334in 2025

2007: 182008: 272009: 372010: 492011: 1552012: 5292013: 1542014: 1552015: 1282016: 2192017: 5362018: 1,4992019: 1,6342020: 1,1712021: 9332022: 1,8342023: 1,0472024: 1,2702025: 1,334
2007high 1,834 (2022) · low 18 (2007)2025

MAUDE reports naming product code LHI, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007389118
20084154327
2009895137
20105139349
201139912155
201251270529
201341023154
20146630155
20153990128
201631591 (1)219
20175561536
20181—3 (3)1,499
2019424711,634
2020318901,171
202133960933
2022627821,834
20235902 (2)1,047
2024916611,270
2025619601,334
20262—1—

What is it indicated for?

The TEVADAPTOR", Drug Reconstitution and Transfer System is a contained system

to be used by pharmacists or other healthcare professionals to prepare drugs, including

cytotoxic drugs, for intravenous infusion or injection.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K051669: Tevadaptor Closed Drug Reconstitution and Transfer System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K051669

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026